Role of the gut microbiota in type 2 diabetes and related diseases

被引：263

作者：

Yang, Ge ^{[1
,2
,3
]}

Wei, Jinlong ^{[1
,3
]}

Liu, Pinyi ^{[1
,2
,3
]}

Zhang, Qihe ^{[1
,2
,3
]}

Tian, Yuan ^{[2
,4
]}

Hou, Guowen ^{[1
,2
,3
]}

Meng, Lingbin ^{[5
]}

Xin, Ying ^{[2
]}

Jiang, Xin ^{[1
,3
]}

机构：

[1] First Hosp Jilin Univ, Dept Radiat Oncol, 71 Xinmin St, Changchun 130021, Peoples R China

[2] Jilin Univ, Key Lab Pathobiol, Minist Educ, 126 Xinmin St, Changchun 130021, Peoples R China

[3] First Hosp Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Changchun 130021, Peoples R China

[4] Second Hosp Jilin Univ, Dept Gynecol, Changchun 130041, Peoples R China

[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Hematol & Med Oncol, Tampa, FL 33612 USA

来源：

METABOLISM-CLINICAL AND EXPERIMENTAL | 2021年 / 117卷

基金：

中国国家自然科学基金;

关键词：

Gut microbiota; Type; 2; diabetes; Nonalcoholic fatty liver disease; Diabetic cardiovascular disease; Diabetic nephropathy; Diabetic retinopathy; Intestinal barrier; Gut microbiota metabolites; Microbiological therapy; FATTY LIVER-DISEASE; LACTOBACILLUS-RHAMNOSUS GG; INNATE LYMPHOID-CELLS; DIET-INDUCED OBESITY; CHAIN AMINO-ACIDS; INTESTINAL MICROBIOTA; MEDITERRANEAN DIET; CARDIOVASCULAR-DISEASE; LACTOCOCCUS-LACTIS; METABOLIC SYNDROME;

D O I：

10.1016/j.metabol.2021.154712

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Type 2 diabetes is the fastest-growing metabolic disease in the world. Many clinical studies have found that type 2 diabetes patients have metabolic disorders and chronic inflammatory states accompanied by disturbances in the gut microbiota. The gut microbiota plays an important role in body metabolism and immune regulation, and disturbances in the gut microbiota in conjunction with destruction of the intestinal barrier in type 2 diabetes patients causes damage to multiple organs. Therefore, the gut microbiota may be a new therapeutic target for treating type 2 diabetes and related diseases. In this review, we introduce the characteristics of the gut microbiota in type 2 diabetes and related diseases, as well as highlight the potential molecular mechanisms of their effects on intestinal barrier disruption, metabolic disorders, and chronic inflammation. Finally, we summarize an intestinal microecological therapeutic strategy, with a focus on shaping the intestinal bacteria, to improve the malignant progress of type 2 diabetes and related diseases. Author summary: Type 2 diabetes (T2D) is the fastest-growing metabolic disease in the world. Many clinical studies have found that T2D patients have metabolic disorders and chronic inflammatory states, accompanied by disturbances of the gut microbiota and increased intestinal permeability. The number of human gut microbiota is more than 10 times of human cells, and they play an important role in the body's metabolism and immune regulation. The abnormal intestinal metabolites and intestinal barrier disruption caused by the gut microbiota dysbiosis in the T2D facilitate intestinal bacteria and their harmful metabolites entering the circulatory system. The abnormal entering will cause the damage to multiple organs through disturbing insulin sensitivity, glucose metabolism, and immune homeostasis. Therefore, the gut microbiota may be a new therapeutic target for improving T2D and its related diseases. In this review, we introduce the compositional characteristics of the gut microbiota in T2D, and highlight some new molecular mechanisms of their effects on intestinal barrier disruption, metabolic disorders and chronic inflammation in T2D and its related diseases. Finally, we summarize an intestinal microecological therapeutic strategy, with a focus on shaping the intestinal bacteria, to improve the malignant progress of T2D and related diseases. ? 2021 Elsevier Inc. All rights reserved.

引用

页数：13

共 193 条

[1] Aberrant intestinal microbiota in individuals with prediabetes [J].

Allin, Kristine H. ;

Tremaroli, Valentina ;

Caesar, Robert ;

Jensen, Benjamin A. H. ;

Damgaard, Mads T. F. ;

Bahl, Martin I. ;

Licht, Tine R. ;

Hansen, Tue H. ;

Nielsen, Trine ;

Dantoft, Thomas M. ;

Linneberg, Allan ;

Jorgensen, Torben ;

Vestergaard, Henrik ;

Kristiansen, Karsten ;

Franks, Paul W. ;

Hansen, Torben ;

Backhed, Fredrik ;

Pedersen, Oluf .

DIABETOLOGIA, 2018, 61 (04) :810-820

[2] Host-Microbe Interplay in the Cardiometabolic Benefits of Dietay Polvphenols [J].

Anhe, F. F. ;

Choi, B. S. Y. ;

Dyck, J. R. B. ;

Schertzer, J. D. ;

Marette, A. .

TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2019, 30 (06) :384-395

[3] Flipping the Metabolic Switch: Understanding and Applying the Health Benefits of Fasting [J].

Anton, Stephen D. ;

Moehl, Keelin ;

Donahoo, William T. ;

Marosi, Krisztina ;

Lee, Stephanie A. ;

Mainous, Arch G., III ;

Leeuwenburgh, Christiaan ;

Mattson, Mark P. .

OBESITY, 2018, 26 (02) :254-268

[4] Branched Chain Amino Acids in Metabolic Disease [J].

Arany, Zoltan ;

Neinast, Michael .

CURRENT DIABETES REPORTS, 2018, 18 (10)

[5] Gut Microbiome in Chronic Kidney Disease [J].

Armani, R. G. ;

Ramezani, A. ;

Yasir, A. ;

Sharama, S. ;

Canziani, M. E. F. ;

Raj, D. S. .

CURRENT HYPERTENSION REPORTS, 2017, 19 (04)

[6] Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation [J].

Atarashi, Koji ;

Suda, Wataru ;

Luo, Chengwei ;

Kawaguchi, Takaaki ;

Motoo, Iori ;

Narushima, Seiko ;

Kiguchi, Yuya ;

Yasuma, Keiko ;

Watanabe, Eiichiro ;

Tanoue, Takeshi ;

Thaiss, Christoph A. ;

Sato, Mayuko ;

Toyooka, Kiminori ;

Said, Heba S. ;

Yamagami, Hirokazu ;

Rice, Scott A. ;

Gevers, Dirk ;

Johnson, Ryan C. ;

Segre, Julia A. ;

Chen, Kong ;

Kolls, Jay K. ;

Elinav, Eran ;

Morita, Hidetoshi ;

Xavier, Ramnik J. ;

Hattori, Masahira ;

Honda, Kenya .

SCIENCE, 2017, 358 (6361) :359-+

[7] A Crucial Role for Diet in the Relationship Between Gut Microbiota and Cardiometabolic Disease [J].

Attaye, Ilias ;

Pinto-Sietsma, Sara-Joan ;

Herrema, Hilde ;

Nieuwdorp, Max .

ANNUAL REVIEW OF MEDICINE, VOL 71, 2020, 2020, 71 :149-161

[8] The gut microbiota as an environmental factor that regulates fat storage [J].

Bäckhed, F ;

Ding, H ;

Wang, T ;

Hooper, LV ;

Koh, GY ;

Nagy, A ;

Semenkovich, CF ;

Gordon, JI .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (44) :15718-15723

[9] Microbiome-Mediated Effects of the Mediterranean Diet on Inflammation [J].

Bailey, Melisa A. ;

Holscher, Hannah D. .

ADVANCES IN NUTRITION, 2018, 9 (03) :193-206

[10] Retinoic acid primes human dendritic cells to induce gut-homing, IL-10-producing regulatory T cells [J].

Bakdash, G. ;

Vogelpoel, L. T. C. ;

van Capel, T. M. M. ;

Kapsenberg, M. L. ;

de Jong, E. C. .

MUCOSAL IMMUNOLOGY, 2015, 8 (02) :265-278

← 1 2 3 4 5 6 7 8 9 10 →